Psoriasis With Leg Involvement, a New Difficult-to-Treat Area: A Cohort Study of Patients Treated With Risankizumab. Dermatology Practical & Conceptual, [S. l.], v. 14, n. 3, p. e2024171, 2024. DOI: 10.5826/dpc.1403a171. Disponível em: https://dpcj.org/index.php/dpc/article/view/4097.. Acesso em: 7 sep. 2024.